461 Pill - beige oval, 10mm

Pill with imprint 461 is Beige, Oval and has been identified as Carbidopa and Levodopa Extended Release 25 mg / 100 mg. It is supplied by Caraco Pharmaceutical Laboratories.

Carbidopa/levodopa is used in the treatment of Parkinson's Disease; Neuroleptic Malignant Syndrome; GTP-CH Deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 461

Carbidopa and levodopa extended release 25 mg / 100 mg 461 Front

Carbidopa and Levodopa Extended Release

Imprint: 461
Strength: 25 mg / 100 mg
Color: Beige
Size: 10.00 mm
Shape: Oval
Availability: Prescription only
Drug Class: Dopaminergic antiparkinsonism agents
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Caraco Pharmaceutical Laboratories
National Drug Code (NDC): 62756-0461
Inactive Ingredients: microcrystalline cellulose, silicon dioxide, hydroxypropyl cellulose (type l), ferric oxide red, D&C Yellow No. 10, hypromelloses, magnesium stearate
Note: Inactive ingredients may vary.